Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Development of single molecule arrays for the quantification of disease biomarkers in menstrual blood
FY 2024-25
Summary
Non-invasive diagnostic tests, such as ultrasounds and urinalysis, improve time to diagnosis and patient outcomes by avoiding common concerns such as safety and discomfort. As a result, non-invasive sample collection is highly desired for accessible biofluid-based disease diagnostics. Menstrual blood is an example of one such sample source; however, its diagnostic potential has been largely overlooked due to barriers such as sample complexity and stigma surrounding menstruation. This proposal aims to develop assays for the quantification of proteins associated with disease within menstrual blood. Specifically, candidate endometriosis biomarkers will be targeted due to the current lack of reliable non-invasive diagnostic tests. Single molecule arrays will be developed for their ultralow (sub-pg/mL) detection limits, thus enabling greater sample dilution and improving measurement accuracy within the complex menstrual blood matrix. These assays will be used to establish baseline concentrations within healthy participants, setting the foundation for future comparison to diseased populations. The outcomes of this research will contribute to the growing body of work investigating menstrual blood as a diagnostic medium for people who menstruate.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529639
Name
Alonzi Sophia M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Development of single molecule arrays for the quantification of disease biomarkers in menstrual blood
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Assay Validation; Biomarkers; Cytokines; Disease Diagnostics; Endometriosis; Immunoassay; Menstrual Blood; Protein Quantification; Single Molecule Arrays; Women'S Health
Abstract
Non-invasive diagnostic tests, such as ultrasounds and urinalysis, improve time to diagnosis and patient outcomes by avoiding common concerns such as safety and discomfort. As a result, non-invasive sample collection is highly desired for accessible biofluid-based disease diagnostics. Menstrual blood is an example of one such sample source; however, its diagnostic potential has been largely overlooked due to barriers such as sample complexity and stigma surrounding menstruation. This proposal aims to develop assays for the quantification of proteins associated with disease within menstrual blood. Specifically, candidate endometriosis biomarkers will be targeted due to the current lack of reliable non-invasive diagnostic tests. Single molecule arrays will be developed for their ultralow (sub-pg/mL) detection limits, thus enabling greater sample dilution and improving measurement accuracy within the complex menstrual blood matrix. These assays will be used to establish baseline concentrations within healthy participants, setting the foundation for future comparison to diseased populations. The outcomes of this research will contribute to the growing body of work investigating menstrual blood as a diagnostic medium for people who menstruate.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Alonzi, Sophia M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~